Apex Biotechnology Corp. (TWSE: 1733)
Health Care · Health Care Equipment & Supplies · TW
NT$32.25
+4.71% today · +6.1% 1Y
Apex Biotechnology Corp. (TWSE: 1733) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $101.23M and employs 641 people.
Over the last twelve months the share price has gained 6.1%, trading between 28.00 and 38.70.
Tweenvest scores Apex Biotechnology Corp. across four factors: quality 76/100, value 56/100, growth 39/100, dividend 86/100. Its strongest factor is dividend.
1733 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $101.23M
- Revenue (TTM)
- $58.67M
- P/E
- 17.06
- EPS
- 1.89
- Dividend yield
- 4.03%
- Beta (5Y)
- 0.25
- 52-week high
- NT$38.70
- 52-week low
- NT$28.00
- Avg volume (3M)
- —
- Shares outstanding
- 99.95M
- Employees
- 641
- Next earnings
- —
About Apex Biotechnology Corp.
Apex Biotechnology Corp. is a Taiwanese firm that specializes in the global development, manufacturing, and distribution of medical devices designed for home use, all powered by sophisticated biosensor technology. Their comprehensive product lineup features a variety of personal health monitoring systems, including those for tracking blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1c, and ketone levels. In addition, the company provides self-testing solutions for coagulation and multi-parameter analysis, alongside advanced hemoglobin screening systems. Beyond patient diagnostics, Apex Biotech also offers systems for detecting pesticide residues. The company further extends its services to include digital care management and telehealth platforms. Established in 1997, Apex Biotechnology Corp. operates from its headquarters located in Hsinchu City, Taiwan.
- ISIN
- TW0001733004
- Founded
- 1997
- Listed since
- Jun 14, 2000
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $114.78 | -1.17% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $369.34 | -0.67% |
| Stryker CorporationNYSE: SYK | $126.81B | $331.48 | +0.27% |
| Medtronic plcNYSE: MDT | $116.66B | $92.13 | +1.09% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.20 | +0.03% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $48.23 | -3.27% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.78 | -0.10% |
Figures last refreshed Aug 18, 2026.